No products in the cart.
Americans for Homeopathy Choice has petitioned the FDA to do three things:
Form an FDA advisory committee on homeopathy.
Withdraw the Draft Guidance on Drug Products Labeled as Homeopathic dated December 2017 which threatens to severely restrict the availability of homeopathic remedies.
Convert Compliance Policy Guidance 400.400 (with minor changes) into a regulation. This is the policy that has guided the agency since 1988 and resulted in high standards of quality assurance in the manufacture of homeopathic remedies even as choice and availability continues to grow.
Right now the FDA has no systematic way to get such input from the homeopathic community. The advisory committee would solve that. Withdrawing the Draft Guidance would lift the threat to homeopathy. Converting the current policy guidance into a regulation would solidify a system that has worked for 30 years and create predictability for manufacturers who could then confidently maintain and expand the variety of remedies they make.
Our petition is now available for public comment and we invite supporters of homeopathy to make comments. Anyone, anywhere can comment! To read the entire petition, -Click here.